New World Evidence Data Market, By Component (Dataset (Claims, Clinical, Pharmacy, and Patient) and Services), By Therapeutic Area (Oncology, Cardiovascular, and Immunology), By End-User (Pharmaceuticals, Medical Devices, Payers, and Providers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Several Partnerships and Innovations in this Field to Support the Growth of the Target Market

Expanding innovations and partnerships among several entities in this field are among the primary drivers propelling the New World Evidence Data Market's expansion. For example, in May 2021, Tempus, Aetion, IQVIA, Flatiron Health, and Syapse joined forces to leverage data from sources other than clinical trials, like as claims and electronic health records. The alliance also made the decision to collaborate with pharmaceutical companies, makers of medical devices, patient associations, and other key players in order to support larger initiatives related to RWE.

New product launches and developments to accelerate market expansion

Another important aspect driving the expansion of the New World Evidence Data Market is the introduction and development of new products in this industry. For example, the Real-World Evidence Registry was established in 2021 by the Real-World Evidence Transparency Initiative, as stated by the International Organization for Pharmacoeconomics and Outcomes Research, a professional association for health economics and outcomes research with headquarters in the United States. By creating a transparent culture for the analysis and reporting of RWE (Real-World Evidence) in healthcare and research, as well as by introducing the RWE registry, the Real-World Evidence Transparency Initiative helps to resolve potential problems with RWE studies.